NCT00798460View on ClinicalTrials.gov

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

PHASE4TerminatedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

November 30, 2010

Conditions

Chronic Hepatitis B

Interventions

DRUG

adefovir

adefovir 10mg

DRUG

clevudine

clevudine 30mg

DRUG

lamivudine

lamivudine 100mg

Trial Locations (1)

411-706

Ilsanpaik hospital, Goyang

Sponsors

Collaborators (1)

Bukwang Pharmaceutical

All Listed Sponsors

collaborator

Bukwang Pharmaceutical

INDUSTRY

lead

Inje University

OTHER

NCT00798460 - Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients | Biotech Hunter | Biotech Hunter